4
Changes in Ownership
Acrivon Therapeutics, Inc. Filed Acc 0000905148-25-003041
Chief Development Officer gave up 403 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
Gamelin Erick · Chief Development Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-08-14 | Shares withheld for taxes : show line 1 in the form | −403 | $1.39 | $560 | 15,686 | D |
Loading xslF345X05/form4.xml…